Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
268 items
minocycline pill bottle in front of retina photo

Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study.
Retinal cross section with photoreceptors and nuclei stained

ALG6 acts as a modifier gene in the inherited genetic eye disease retinitis pigmentosa 59

Variant of ALG6 delays rod photoreceptor degradation but decreases cone health in people with RP59 retinitis pigmentosa, according to a new study from University of Alabama, Birmingham.

Babies attend to clues of meaning as they take in complex visual world

Findings from a National Eye Institute-supported study show for the first time that when babies look at photos of unfamiliar everyday scenes, such as an office or a lab, they tend to fixate on the same regions where adults find meaning.

AI has perfect detection rate for severe cases of condition that causes blindness in preemies

Research shows that an artificial intelligence technology developed with NEI funding can accurately and independently detect all severe cases of retinopathy of prematurity.
fundus photo showing diabetic retinopathy

Some ethnic groups at higher risk for retinal damage from diabetes

Researchers at Indiana University School of Optometry found that individuals are at different risks for retinal damage from diabetes, with certain ethnic groups and males being at a greater risk.

University of Houston expert warns red light myopia therapy can injure retina

A University of Houston optometry researcher is warning against the use of low-level red light (LLRL) therapy as a method to control myopia, or nearsightedness, especially in children.
Scientist examines scientific images on a screen in a dark room.

Retinal imaging and genetics data used to predict future disease risk

Researchers combined retinal imaging, genetics and big data to estimate how likely a person is to develop eye and systemic diseases in the future.
Woman reading eye chart

Mega-analysis identifies gene variants associated with glaucoma in people of African ancestry

A new analysis focusing specifically on people of African ancestry identified three gene variants that may be contributing to this population’s susceptibility to developing and being blinded by glaucoma.
Eye doctor giving patient an eye exam.

Study finds AI–driven eye exams increase screening rates for youth with diabetes

A study of children and youth with diabetes concludes that diabetic eye exams using artificial intelligence (AI) increase completion rates of screenings to detect diabetic eye disease.

NEI hosts first workshop on brain-based vision disorder

The National Institutes of Health sponsored its first-ever workshop on cerebral visual impairment (CVI), an umbrella term for subnormal vision resulting from brain injury during development.